IMARC Group, a leading market research company, has recently releases report titled “Radiodermatitis Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028”, Offers a comprehensive analysis of the industry, which comprises insights on the radiodermatitis market share.
How Big is the Radiodermatitis Market?
The global radiodermatitis market size reached US$ 481.9 Million in 2022. Looking forward, IMARC Group expects the market to reach US$ 597.9 Million by 2028, exhibiting a growth rate (CAGR) of 3.5% during 2023-2028.
Industry Overview of Radiodermatitis
Radiodermatitis, also known as radiation dermatitis, refers to a skin condition that is caused by radiation therapy during the treatment of several cancers, such as breast, lungs, skin, neck, and head among individuals. It causes itching, redness, peeling, soreness, blisters, swelling, and flaking in the body. It can be treated through topical antibiotics, hydrogel and hydrocolloid dressings, silicone-coated dressings, corticosteroids, hydrophilic creams, silver-leaf dressings, anti-inflammatory agents, and oral analgesics.
For an in-depth analysis, you can refer sample copy of the report: https://www.imarcgroup.com/radiodermatitis-market/requestsample
What are the growth prospects and trends in the radiodermatitis industry?
At present, the increasing prevalence of various cancers among individuals across the globe represents one of the key factors contributing to the growth of the market. Additionally, the increasing demand for effective treatment options to enhance the quality of life of patients is bolstering the growth of the market.
Besides this, the growing demand for topical antibiotics, as they are easily accessible, cost-efficient, easy to use, and reduce the risk of microbiological transmission among individuals, is offering a positive market outlook. Moreover, the wide availability of radiodermatitis treatment drugs through online and offline pharmacy stores is offering lucrative growth opportunities to industry investors.
Apart from this, governing agencies and private healthcare organizations of various countries are spreading awareness about the management and treatment of radiodermatitis worldwide, which is strengthening the growth of the market. Furthermore, key players are introducing effective therapies for treating radiodermatitis, which is impelling the growth of the market.
Leading Companies Operating in the Global Radiodermatitis Industry:
- 3M Company
- Bausch Health Companies Inc.
- Bayer AG
- BMG PHARMA S.p.A.
- Charles River Laboratories International Inc.
- ConvaTec Group plc
- Helsinn Healthcare SA
- ICON plc
- Integra LifeSciences
- Mölnlycke Health Care AB
- Stratpharma AG.
Radiodermatitis Market Report Segmentation:
The report has segmented the market into the following categories:
Breakup by Product:
- Topical
- Corticosteroids
- Hydrophilic Creams
- Antibiotics
- Others
- Oral
- Dressings
- Hydrogel and Hydrocolloid Dressings
- No Sting Barrier Film
- Honey Impregnated Gauze
- Silicone Coated Dressings
- Others
Breakup by Distribution Channel:
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
Breakup by Region:
- North America: (United States, Canada)
- Asia Pacific: (China, Japan, India, South Korea, Australia, Indonesia, Others)
- Europe: (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
- Latin America: (Brazil, Mexico, Others)
- Middle East and Africa
If you require any specific information that is not covered currently within the scope of the report, we will provide the same as a part of the customization.
About Us
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC Group’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact US
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email: sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
United States: +1-631-791-1145 | United Kingdom: +44-753-713-2163
